WRKY30 Antibody

What is WRKY30 and why is it significant in plant immunity research?

WRKY30 belongs to the WRKY family of transcription factors, which are key regulators of plant stress responses. In Arabidopsis, WRKY30 plays essential roles in regulating resistance to Cucumber mosaic virus (CMV), with its expression being induced by CMV infection. The WRKY30 overexpression plants (WRKY30OX) exhibit enhanced resistance to CMV infection, whereas wrky30 mutants display increased susceptibility, including higher oxidative damage and compromised photosystem II photochemistry . In tomato, SlWRKY30 positively regulates resistance to Ralstonia solanacearum, a devastating bacterial pathogen causing bacterial wilt disease . Understanding WRKY30's function provides valuable insights for developing disease-resistant crop varieties.

What are the key applications for WRKY30 antibodies in plant immunity research?

WRKY30 antibodies serve multiple critical functions in plant immunity research:

• Detection and quantification of WRKY30 protein levels in different tissues or under various stress conditions

• Immunolocalization to determine subcellular localization patterns

• Chromatin immunoprecipitation (ChIP) assays to identify DNA-binding sites

• Co-immunoprecipitation experiments to identify protein-protein interactions

• Western blot analysis to confirm protein expression in transgenic plants

These applications help researchers understand how WRKY30 contributes to plant immunity at the molecular level, including its regulation of downstream target genes like PR-STH2 in tomato .

How do WRKY30 expression patterns change during pathogen infection?

WRKY30 expression is strongly induced during pathogen infection. In Arabidopsis, WRKY30 expression increases upon CMV infection . Similarly, in tomato, SlWRKY30 is strongly induced by Ralstonia solanacearum infection (RSI) . This pathogen-induced expression pattern confirms WRKY30's role in plant defense responses. WRKY30 antibodies are essential for tracking these expression changes at the protein level, particularly when transcriptional upregulation may not directly correlate with protein abundance due to post-transcriptional regulation mechanisms.

What are the best protocols for using WRKY30 antibodies in Western blot analysis?

For optimal Western blot results with WRKY30 antibodies:

• Sample preparation:

  • Extract total protein from plant tissues using a buffer containing 50 mM Tris-HCl (pH 7.5), 150 mM NaCl, 1 mM EDTA, 10% glycerol, 1% Triton X-100, and protease inhibitor cocktail

  • Quantify protein concentration using Bradford assay or BCA method

• SDS-PAGE and transfer:

  • Separate proteins using 10-12% SDS-PAGE gels

  • Transfer to PVDF membrane (0.45 μm) at 100V for 1 hour or 30V overnight

• Immunoblotting:

  • Block membranes with 5% non-fat dry milk in TBST for 1 hour at room temperature

  • Incubate with primary WRKY30 antibody (1:1000-1:2000 dilution) overnight at 4°C

  • Wash 3× with TBST, 10 minutes each

  • Incubate with HRP-conjugated secondary antibody (1:5000-1:10000) for 1 hour at room temperature

  • Detect using chemiluminescence substrates similar to those used for Cas9 detection in gene editing studies

Expected results: WRKY30 protein from Arabidopsis appears at approximately 35-40 kDa, while SlWRKY30 from tomato is around 37 kDa.

How can WRKY30 antibodies be used for chromatin immunoprecipitation (ChIP) assays?

ChIP assays with WRKY30 antibodies are crucial for identifying direct binding targets:

• Chromatin preparation:

  • Cross-link plant tissue with 1% formaldehyde for 10 minutes under vacuum

  • Quench with 0.125 M glycine

  • Extract and shear chromatin to 200-500 bp fragments using sonication

• Immunoprecipitation:

  • Pre-clear chromatin with Protein A/G beads

  • Incubate chromatin with WRKY30 antibody (2-5 μg) overnight at 4°C

  • Add protein A/G beads and incubate for 2-3 hours

  • Wash beads sequentially with low salt, high salt, LiCl, and TE buffers

• DNA recovery and analysis:

  • Reverse cross-linking at 65°C overnight

  • Treat with RNase A and Proteinase K

  • Purify DNA and analyze by qPCR or sequencing

This approach has been valuable in identifying binding targets of WRKY TFs, as demonstrated in studies of WRKY50 binding to WT-box elements in the WRKY30 promoter . WRKY30 would similarly bind to W-boxes or WT-boxes in promoters of defense-related genes.

What considerations are important when performing immunolocalization studies with WRKY30 antibodies?

For effective WRKY30 immunolocalization:

• Sample preparation:

  • Fix plant tissues in 4% paraformaldehyde

  • Embed in paraffin or prepare frozen sections

  • For subcellular localization, isolate protoplasts or use tissue sections

• Antibody application:

  • Use antigen retrieval if necessary (citrate buffer, pH 6.0)

  • Block with 3% BSA in PBS with 0.1% Triton X-100

  • Incubate with WRKY30 antibody (1:100-1:200) overnight at 4°C

  • Use fluorescently labeled secondary antibody (1:500)

• Visualization and controls:

  • Include DAPI staining to visualize nuclei (WRKY30 should show nuclear localization)

  • Use wrky30 mutant tissue as a negative control

  • Compare with GFP-tagged WRKY30 localization patterns if available

Expected results: WRKY30 typically shows nuclear localization, consistent with its function as a transcription factor, with potential enhanced nuclear accumulation following pathogen challenge.

How can researchers distinguish between different WRKY family members when using antibodies?

Distinguishing between WRKY family members requires careful antibody selection and validation:

• Epitope selection strategies:

  • Target unique regions outside the conserved WRKY domain

  • Focus on N-terminal or C-terminal regions with higher sequence divergence

  • Consider using peptide antibodies against unique sequences

• Validation approaches:

  • Perform Western blots with recombinant proteins of multiple WRKY family members

  • Include knockout/mutant lines as negative controls

  • Use overexpression lines as positive controls

  • Perform immunoprecipitation followed by mass spectrometry

• Cross-reactivity assessment:

  • Test antibodies against closely related WRKYs, particularly within the same group (WRKY30 belongs to Group III)

  • In tomato, assess cross-reactivity with SlWRKY52, SlWRKY59, SlWRKY80, and SlWRKY81, which interact with SlWRKY30

  • In Arabidopsis, evaluate potential cross-reactivity with other Group III WRKYs

This distinction is particularly important when studying WRKY30, as it shares structural similarities with other Group III WRKY proteins that have overlapping functions in plant immunity.

How do post-translational modifications affect WRKY30 antibody recognition?

Post-translational modifications (PTMs) can significantly impact antibody recognition of WRKY30:

• Common PTMs affecting WRKY proteins:

  • Phosphorylation (particularly by MAPKs during immune responses)

  • Ubiquitination (affecting protein stability)

  • SUMOylation (modulating transcriptional activity)

• Effects on antibody binding:

  • Phosphorylation-specific antibodies can detect activated WRKY30

  • Standard antibodies may show reduced binding to heavily modified protein

  • Conformational changes due to PTMs can mask or expose epitopes

• Methodological considerations:

  • Include phosphatase treatment in control samples to evaluate phosphorylation effects

  • Use phosphorylation-specific antibodies for activated WRKY30 detection

  • Consider native vs. denaturing conditions for different epitope accessibility

Understanding these modifications is crucial for interpreting experimental results, as WRKY30 activity in plant immunity pathways is likely regulated by PTMs in response to pathogen recognition signals.

What approaches can resolve contradictory results when studying WRKY30 using antibody-based methods?

When facing contradictory results with WRKY30 antibodies:

• Antibody validation strategies:

  • Verify antibody specificity using multiple approaches (Western blot, immunoprecipitation)

  • Test antibody with recombinant WRKY30 protein

  • Use wrky30 knockout/mutant lines as negative controls

  • Compare results with epitope-tagged WRKY30 detected by tag-specific antibodies

• Experimental design considerations:

  • Standardize growth conditions and pathogen challenge protocols

  • Document exact tissue types, developmental stages, and timing post-infection

  • Consider diurnal regulation of WRKY expression

• Complementary approaches:

  • Employ multiple antibody-independent techniques (transcript analysis, reporter gene assays)

  • Use proteomic approaches to validate results

  • Perform genetic complementation of wrky30 mutants

This comprehensive validation is important given that studies in Arabidopsis initially hypothesized WRKY30 might be an essential gene, but successful generation of wrky30 deletion mutants demonstrated otherwise .

How do WRKY30 proteins differ between plant species, and what implications does this have for antibody selection?

WRKY30 shows important differences between plant species that affect antibody selection:

When selecting or developing antibodies:

• Assess sequence homology between species (typically 50-70% conserved)

• Test cross-reactivity if using antibodies across species

• Consider raising antibodies against synthetic peptides unique to the species of interest

• Validate specificity in each species with appropriate controls

These differences are important for experimental design, as antibodies developed against AtWRKY30 may not recognize SlWRKY30 with the same affinity or specificity.

How can researchers study interactions between WRKY30 and other WRKY transcription factors using antibodies?

To study WRKY30 interactions with other WRKYs:

• Co-immunoprecipitation strategies:

  • Use WRKY30 antibodies to pull down protein complexes from plant extracts

  • Identify interacting partners using Western blot with antibodies against other WRKYs

  • In tomato, focus on SlWRKY52, SlWRKY59, SlWRKY80, and SlWRKY81, which interact with SlWRKY30

  • Confirm interactions in both forward and reverse co-IP experiments

• Proximity-based approaches:

  • Perform bimolecular fluorescence complementation (BiFC) with epitope-tagged constructs

  • Use proximity ligation assays (PLA) with antibodies against WRKY30 and potential partners

  • Combine with FRET-FLIM using fluorescently tagged proteins

• DNA-binding complex analysis:

  • Perform sequential ChIP (Re-ChIP) to identify co-occupancy of promoters

  • Use electrophoretic mobility shift assays with antibodies to supershift complexes

  • Correlate with transcriptional changes of target genes like SlPR-STH2a/b/c/d in tomato

These approaches have revealed that SlWRKY30 and SlWRKY81 synergistically regulate resistance to R. solanacearum by activating expression of pathogenesis-related proteins .

What insights can WRKY30 antibodies provide about the evolution of plant immunity mechanisms?

WRKY30 antibodies can illuminate evolutionary aspects of plant immunity:

• Comparative analysis across plant lineages:

  • Use antibodies to assess WRKY30 conservation in different plant families

  • Compare protein size, abundance, and localization patterns across species

  • Evaluate conservation of protein-protein interaction networks

• Functional conservation assessment:

  • Determine if WRKY30 recognizes similar DNA motifs across species

  • In Arabidopsis, WRKY50 binds to WT-boxes in the WRKY30 promoter

  • Compare regulation of orthologous target genes across species

• Stress-response profiling:

  • Use antibodies to compare WRKY30 induction patterns across species

  • Assess whether WRKY30 responds to the same pathogens and signals

  • Evaluate speed and magnitude of response in basal versus species-specific immunity

These evolutionary insights are valuable for understanding how plant immune systems adapted to different pathogens, potentially informing approaches to develop broad-spectrum disease resistance in crops.

What are the optimal sample preparation methods for preserving WRKY30 integrity in different applications?

Sample preparation significantly impacts WRKY30 detection:

• For Western blotting and immunoprecipitation:

  • Extract proteins in cold buffer containing 50 mM Tris-HCl (pH 7.5), 150 mM NaCl, 1% Triton X-100, 1 mM EDTA, 10% glycerol

  • Include protease inhibitors (PMSF, leupeptin, aprotinin)

  • Add phosphatase inhibitors (NaF, Na₃VO₄) to preserve phosphorylation states

  • Process samples quickly at 4°C to minimize degradation

  • Consider adding N-ethylmaleimide to preserve SUMOylation

• For immunohistochemistry and immunofluorescence:

  • Fix tissues in 4% paraformaldehyde for 2-4 hours

  • For better nuclear protein preservation, include 0.1% glutaraldehyde

  • Test different antigen retrieval methods (heat-induced in citrate buffer)

  • Optimize permeabilization conditions (0.1-0.5% Triton X-100)

• For chromatin immunoprecipitation:

  • Cross-link tissues in 1% formaldehyde for precisely 10 minutes

  • Quench with 0.125 M glycine

  • Optimize sonication conditions for each tissue type

  • Verify chromatin fragmentation to 200-500 bp by gel electrophoresis

Proper sample preparation is crucial for detecting WRKY30, especially when studying its DNA-binding properties in chromatin contexts.

How can researchers develop and validate custom WRKY30 antibodies for specialized applications?

For developing custom WRKY30 antibodies:

• Antigen design strategies:

  • Select unique regions with high antigenicity and surface exposure

  • Avoid the conserved WRKY domain to minimize cross-reactivity

  • Consider using full-length recombinant protein for polyclonal antibodies

  • Use synthetic peptides from unique regions for higher specificity

• Production considerations:

  • Compare polyclonal (broader epitope recognition) vs. monoclonal (higher specificity)

  • For monoclonals, screen multiple clones for optimal specificity and sensitivity

  • Consider species of origin to minimize background in immunohistochemistry

• Validation requirements:

  • Test against recombinant WRKY30 protein

  • Verify absence of signal in wrky30 mutant/knockout plants

  • Confirm expected molecular weight in Western blots

  • Assess cross-reactivity with other WRKY family members

  • Validate in multiple applications (Western blot, ChIP, immunofluorescence)

Custom antibodies are particularly valuable for species where commercial WRKY30 antibodies aren't available or for detecting specific post-translational modifications relevant to immune signaling.

What are the critical controls needed when performing ChIP-seq with WRKY30 antibodies?

ChIP-seq with WRKY30 antibodies requires rigorous controls:

• Experimental controls:

  • Input DNA (pre-immunoprecipitation) for normalization

  • IgG control (non-specific antibody) to establish background

  • ChIP in wrky30 mutant/knockout plants as negative control

  • ChIP with epitope-tagged WRKY30 as complementary approach

  • Include known WRKY30 target regions as positive controls

• Technical validation:

  • Perform ChIP-qPCR on selected regions before sequencing

  • Assess enrichment at known target genes (WRKY30 targets W-box or WT-box elements)

  • Evaluate biological replicates for reproducibility

  • Include spike-in controls for quantitative comparisons

• Bioinformatic considerations:

  • Use appropriate peak-calling algorithms for transcription factor binding

  • Perform motif enrichment analysis (expect W-box or WT-box motifs)

  • Compare binding patterns before and after pathogen infection

  • Integrate with transcriptomic data to correlate binding with gene expression

These controls are essential for generating reliable ChIP-seq data that accurately represents WRKY30 binding sites across the genome, as exemplified by studies of WRKY binding to target gene promoters containing WT-box elements .